INS and Insulin resistance: T2DM is characterized by both insulin resistance (as manifested by reduced insulin-stimulated glucose uptake in skeletal muscle and adipose tissue and inappropriately high hepatic glucose output [3],[4]) and reduced insulin secretion by pancreatic β-cells [3],[5].